Co‑injecting three common amino acids with LNPs dramatically boosted both mRNA delivery and CRISPR gene editing efficiency in preclinical models.

Lipid nanoparticles, or LNPs, are best known as the delivery system used in the COVID-19 mRNA vaccines given to billions of people worldwide. Scientists are now exploring their potential far beyond ...

Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...

In recent years, mRNA in lipid nanoparticles (mRNA–LNPs) has emerged as a promising strategy for treating numerous conditions, including COVID-19, various cancers and chronic genetic disorders. To ...

The American College of Physicians (ACP) has recommended that adults aged 65 years or older receive updated 2025–2026 mRNA-based COVID-19 vaccines, according to February guidelines published in Annals ...

CHMP adopts positive opinion on Moderna’s mRNA combination vaccine ‘mCOMBRIAX’ against influenza, Covid-19: Cambridge, Massachusetts Wednesday, March 4, 2026, 16:00 Hrs [IST ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

Two scientists who worked on the science behind the COVID-19 vaccine earned the prestigious 2023 Nobel Prize in Physiology or Medicine. Katalin Karikó and Dr. Drew Weissman, both University of ...